A Clinical Study to Evaluate CAD-1883 in Essential Tremor
NCT03688685
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Essential Tremor
Interventions
DRUG:
CAD-1883
Sponsor
Cadent Therapeutics